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Summary
The objectives were to determine urinary iodine concen-
tration (UIC) in day and night samples collected over a
24-hour period and evaluate the usual dietary iodine in-
take distribution from this collection. We propose a method
by which the prevalence of inadequacy can be calculated
from a single 24-hour collection, reducing the burden on
participants and the study costs.
The samples from 1128 participants were collected be-
tween 2009 and 2013 within the framework of the Swiss
Kidney Project on Genes observational cohort study; 1024
samples were suitable for statistical evaluation of iodine
analysis. Participants were over 18, resident in Switzer-
land and of European ancestry. Over 24 hours, urine was
collected as night-time (bedtime until and including first
morning urine) and day-time (the remainder) samples. As-
sociations with variables, in particular to estimated
glomerular filtration rate (eGFR), were investigated using
mixed models.
The 24-hour median UICs were 73 and 96 µg/l for women
(n = 542) and men (n = 482), respectively; 24-hour median
intakes (derived from the corresponding excretion) were
127 and 156 µg/d, respectively. Day and night excretions
were normalised to 24-hour excretion values and the usual
intake distribution calculated by the US National Cancer
Institute method. The Estimated Average Requirement
cut-point method was used to calculate the prevalence of
inadequacy, estimated at 14% for women and 4% for men;
above the target of 2-3%.
We conclude that segregating 24-hour urine into day and
night collections is sufficient to determine the prevalence
of iodine inadequacy in the population and reduces the
burden on participants by sparing a second 24-hour col-
lection. No association between iodine intake and eGFR
was found.
Keywords: urinary iodine, Switzerland, diurnal variation,
24-hour urine, EAR cut-point method, estimated glomeru-
lar filtration rate
Introduction
Iodine is the heaviest, stable, naturally occurring halogen.
It is also the least abundant, with 70% occurring in ocean
sediments [1] and only low concentrations in soils. A key
step in the iodine cycle is volatilisation from the oceanic
“reservoir” into the atmosphere [2]. Deposition of iodine
occurs mainly in coastal regions via sea spray and precipi-
tation [2]. For regions whose water supply originates from
spring and ground water, drinking water can be an impor-
tant source of iodine for the population [3]. This is not the
case for Switzerland [4], a land-locked country, known his-
torically for its prevalence of iodine deficiency [5].
Of all foodstuffs, iodine is found in highest concentrations
in seafood and seaweeds [6], with bread, eggs and dairy
products also being important sources. The mean iodine
concentration in fruits, vegetables, grains and meat is ex-
tremely low owing to the limited uptake of iodine by plants
[2], although there are moves to increase the iodine level
of crops in some countries [7]. The iodine content of dairy
products results from several factors; food supplements
(causing a seasonal variation [8], note the recommendation
to lower maximum permitted iodine content of animal feed
[9]), teat dipping and processing [10]; organic (lower) vs
traditional methods [11–13]. Bread is the largest source of
iodine in the Swiss diet [5], due to iodised salt added be-
fore the baking process. Overall, 87% of Swiss bakeries
use iodised salt [14]. Indeed, iodised salt was used to bring
iodine deficiency under control in Switzerland. Following
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a drive to lower the salt consumption of the Swiss popula-
tion [15], measures were taken to stabilise the consumption
of iodine by increasing the iodine concentration in table
salt from 20 to 25 ppm [16]. Since table salt is estimated to
make up only 11% of consumption (75% from processed
foods [17]), it is encouraged that industrial products con-
tain iodised salt. With the majority of iodine-containing
foods being animal based, vegans in particular should en-
sure they have neither a deficient nor an excessive iodine
intake [18]. A recent nationwide survey [19] suggested that
0.4% of the Swiss population follows a vegan diet, with a
higher incidence among women (0.52%) than men (0.21%)
[20]. Other, non-nutritive, sources of iodine are disinfec-
tants and medication.
Iodine is classified as an essential micronutrient and is
found corporeally almost entirely in the thyroid gland [21],
in the thyroid hormones triiodothyronine (T3) and thyrox-
ine (T4). An estimated 15–20 mg is present in the body in
total [22]. Thyroid hormones are required for the growth
and development of most organs, including the brain. A
lack of maternal iodine during pregnancy can lead to irre-
versible cognitive impairment or even miscarriage, and a
lack of iodine as a young child can lead to mental impair-
ment and a lower than expected intelligence quotient [23].
Follow-on effects are a reduced mental capacity affecting
home, school and work life. Iodothyronine deiodinase is
a family of enzymes containing the amino acid selenocys-
teine. It plays an important role in the transformation of
T4 into T3 and protection of the thyroid from damage by
peroxide. Therefore adequacy of both selenium and iodine
may be interrelated [24]. The selenium status of the Swiss
population is currently adequate [25].
The WHO recommends a daily intake of iodine of 150 µg
for anyone over the age of 12, and 200 µg for pregnant and
lactating women [26]. Although urinary iodine concentra-
tion (UIC) is considered the most practical biochemical
marker for iodine nutrition [26], it provides only a snapshot
of iodine excretion at the time of measurement. Median
values of 100–199 µg/l are considered to be adequate and
to represent a population with no iodine deficiency. The
populations of 54 countries are currently considered iodine
deficient [27]. UIC above 300 µg/l is considered excessive
[26] and the tolerable upper intake level is set at 1100 µg
per day [28]. EFSA advise the same adequate intake value
as the WHO [29]. For children and adults over the age of
14, the Institute of Medicine (US) Panel on Micronutrients
specify a recommended dietary allowance of 150 µg/d and
an estimated average requirement (EAR) of 95 µg/d, valid
for both sexes [30]. The EAR cut-point method allows es-
timation of the prevalence of inadequate intakes calculated
as the proportion of the population with intakes below the
EAR [31]. The Swiss Federal Food Safety and Veterinary
Office recommendations are in line with those of the WHO
[32].
In a healthy adult, 92% of ingested iodine is filtered out
by the kidneys and excreted in urine [33], making 24-hour
urine collections the reference standard for iodine intake
assessment, albeit often impractical to implement. It is also
representative of the total daily intake, an advantage over
the use of food frequency questionnaires. Excretion occurs
4–5 hours after ingestion and an equilibrium between in-
take and excretion is expected to be established, with most
being excreted within a day [34]. The estimated glomerular
filtration rate (eGFR) is used as a measure of kidney health
and function. Als et al. have shown iodine excretion to be
subject to a diurnal variation [35], suggesting that timing
of spot urine samples should be taken into account with a
morning fasting spot sample avoided [34, 36]. Although at
first sight this seems in contrast to the study by Perrine et
al., who found that the timing did not affect assessment of
intake [37], in the latter study, samples were grouped to-
gether by time period rather than treated as individual spot
samples.
The primary aim of the current study was to explore
whether or not the prevalence of iodine inadequacy in the
population can be calculated from a single 24-hour urine
collection, if this collection is segregated into night-time
and day-time periods. Secondly, the study aimed to iden-
tify potential associations between iodine intake/excretion
and factors such as eGFR. The relevant data were collected
within the framework of the population based Swiss Kid-
ney Project on Genes in Hypertension (SKIPOGH).
Methods
SKIPOGH is a family-based cohort of the Swiss popula-
tion in the regions of Bern, Geneva and the city of Lau-
sanne in the Canton of Vaud. The primary aim of the
project is to explore the role of genes in blood pressure reg-
ulation and kidney function; secondarily, it is a biomoni-
toring survey. In brief, the baseline examination took place
between December 2009 and March 2013. Using differ-
ent strategies, a random sample of adults from the three
aforementioned regions of Switzerland were drawn. Four
requirements had to be met: (i) age at least 18 years, (ii)
European ancestry, (iii) at least one first degree family
member also willing to participate, and (iv) provision of
written, informed consent. Pregnant or breastfeeding
women were not included. The general participation rate
was 25.6% [38]. A more detailed description of the meth-
ods can be found elsewhere [39, 40].
The SKIPOGH study was conducted according to the
guidelines laid down in the Declaration of Helsinki (2008)
of the World Medical Association and all procedures in-
volving human subjects were approved by the Ethics Com-
mittees of each participating university hospital: Human
Research Ethics Committee, Lausanne University Hospital
and University of Lausanne (Lausanne, Switzerland); the
Ethics Committee for the Research on Human Beings,
Geneva University Hospitals (Geneva, Switzerland), and
the Ethics Committee of the Canton of Bern, (Bern,
Switzerland); CER-VD: 92/07; CER-GE: 09-089; CER-
BE: 091/09; amendment for urinary iodine: CER-VD: 303/
12. Written informed consent was obtained from all sub-
jects.
Participants attended hospital after an overnight fast (water
and medication permitted). Body weight, to the nearest 100
g, was measured in kg (electronic scales, Seca, Germany)
and height in cm, to the nearest 0.5 cm (height gauge, Seca,
Germany). Body mass index (BMI) was calculated by di-
viding weight (kg) by height squared (m2). Fasting ve-
nous blood samples and a 24-hour urine sample were col-
lected, from which electrolytes, kidney function and blood
glucose were measured using standard clinical laboratory
methods [41]. Creatinine was measured using IDMS-trace-
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able methods [42] and eGFR was calculated according to
the CKD-EPI creatinine equation developed by the Chron-
ic Kidney Disease Epidemiology Collaboration [43].
Urine was collected separately for day and night, covering
a 24-hour period. Each of the 1128 participants determined
what constituted night-time (bedtime up to and including
the first urine of the morning) and day-time (the remain-
der). The study adopted this choice, rather than a time lim-
it, in order to explore the circadian rhythm of blood pres-
sure [44]. Please note that in this paper we classify the time
of collection as: night-time – collection from when the par-
ticipant went to bed and including the first urine of the
morning; day-time – collection during the remainder of the
24 hour period; not be confused with 24-hour UIE which
is the total of the two; night-time:24-hour normalised –
normalisation of the night time collection to 24-hours by a
scaling factor calculated from reported sleeping and wak-
ing times, and day-time:24-hour normalised calculated
from the corresponding waking hours of the participant.
Urine samples were judged for incompleteness by criteria
applied in similar studies: creatinine <0.6 mmol/d and vol-
ume <1000 ml; creatinine <5.0 mmol/d [45]. Cases were
also rejected if participants self-reported incompleteness of
urine sample collection, if they were taking iodine-contain-
ing medication or if basic data were missing.
UICs were measured with an isotope dilution, inductively
coupled plasma-mass spectrometry method as described
elsewhere [46]. A urine quality control sample (NIST
SRM 2670a, certified iodine content 88.2 [standard devia-
tion 1.1] µg/l; National Institute of Standards and Technol-
ogy, Gaithersburg, MD, USA) was included in every run.
Blank solutions were routinely prepared and tested in order
to monitor potential iodine cross-contamination from the
urine samples. The mean limit of observed values was 88.4
(SD 0.73) µg/l (n = 129) for the certified reference mate-
rial. Creatinine was measured with the Jaffe kinetic-com-
pensated method. Calcium and sodium were measured by
means of flame photometry (IL-943, Instrumentation Lab-
oratory, Milano, Italy). Selenium was measured with ICP-
MS as described elsewhere [47].
Statistical analysis
Systat 13.0 statistical software (Systat, Chicago, IL, USA)
was used for data analysis and, with Excel, graphics gen-
eration. Continuous variables are described as either mean
and standard deviation if data followed the normal dis-
tribution, or median, and 25th and 75th percentiles for
non-normally distributed data. Sample acquirement is split
evenly over the four seasons, therefore this was not taken
into account as a weighting factor when calculating mean
and median values [48, 49]. Categorical variables are de-
scribed as numbers and percentages. Mann-Whitney tests,
t-tests or chi-square tests were used as appropriate in order
to compare groups. Pearson tests were carried out to ascer-
tain correlations of continuous variables. A p value of less
than 0.05 was considered to be significant in all tests (p
<0.05).
Determination of associated factors
Twenty four-hour urinary iodine excretion (UIE) was used
as a proxy for intake and the general linear model (GLM)
procedure was run to identify the explanatory variables.
After loss of data due to list-wise deletion of participants
with missing data, general linear mixed effects models
were pursued. Mixed models analysis allows missing data
as long as it is missing at random and the inclusion of all
data points of the dependent variable despite incomplete
data points across the explanatory variables [50]. Initially,
sex, season of urine sample, daily vegetable consumption,
weekly meat and fish consumption, smoking status and
canton of residence (categorical independent variables)
were taken as fixed factors. Fixed covariates (continuous,
observed variables) were set to be age, BMI, plasma se-
lenium, eGFR and 24-hour urinary selenium, calcium and
sodium excretions. Variables with highest p-values were
eliminated in turn and Bayesian information criterion
(BIC) and Akaike information criterion (AIC) values com-
pared. The fits of the best models were evaluated graphi-
cally, by assessment of normality of the residuals and by
plotting the standardised residuals against predicted iodine
values; the model with the lowest BIC and AIC values was
selected.
Risk of inadequacy
In order to estimate the prevalence of inadequacy of iodine
intake in the Swiss population, the EAR cut-point method
proposed by Beaton was used [51]. An intake equal to the
EAR value (95 µg/d for iodine) will by definition satis-
fy the needs of 50% of people within the criteria of the
group; thus the proportion below this value estimates the
percentage of the population at risk of inadequacy. Three
assumptions are made: (i) intakes and requirements are in-
dependent, (ii) the requirement distribution is symmetrical
around the EAR and (iii) the variance of intakes is larg-
er than the variance of requirements [52]. If these assump-
tions are satisfied, only the EAR and the distribution of
usual intakes are required to determine inadequacy.
The usual intake distribution was estimated from the ob-
served intake distribution by adjusting for and partially re-
moving the intra-individual variance [52]. The National
Cancer Institute (NCI), US, has developed a model to esti-
mate the usual dietary intakes of foods and nutrients based
on repeat daily intakes [53]. To this end, the NCI macros
Mixtran and Distrib [54] were run in the statistical soft-
ware package Statistical Analysis Systems version 9.4
(SAS Institute, Cary, NC, USA). In order to obtain the usu-
al intake distributions via the NCI method, at least two in-
takes must be available for some of the individuals in the
group [53]. Day-time and night-time UIE was normalised
to a 24-hour excretion using a time scaling factor based on
the duration of urine collection in minutes [37], (excretion/
reported duration)*1440, so providing replicate intakes for
each case to be used for the adjustment. Stratification by
age was not necessary since the statistical analysis showed
age not to be a significant variable.
The usual iodine intake distributions were estimated using
the NCI method for males and females; both the full con-
tingent and the subset of women of reproductive age, typ-
ically aged 15–49, Note: age of consent for this study is
18). Since age was not significant in the explanation of the
model, only the results for the full contingent are reported
in detail here.
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Results
From an initial study size of 1128 participants, samples
were rejected because of: incomplete iodine data (n = 79);
incomplete volume data (n = 1); excessive intakes, UIE
>590 µg/d, not resulting from food (n = 17, range
593–15946 µg/d); creatinine <0.6 mmol/d and volume
<1000 ml (n = 3); and creatinine <5.0 mmol/d (n = 4)
[45]. This left a sample size of 1024 available for statistical
analysis.
The main characteristics of the study population (542
women, 482 men) aged 18–90 years old are described in
table 1. The distribution of the 24-hour UIE data for all
1024 participants is unimodal and skewed, lognormal (A
= 0.328, n = 1024, p >0.15). A difference between the
24-hour excretion of men vs women is apparent, with me-
dians of 144 and 117 µg/d, respectively (U = 92126, nM =
482, nF = 542, p <0.001), as depicted in figure 1. The 1024
participants provided both a night-time and day-time urine
sample. Observed night-time iodine excretion is lower than
day-time (fig. 1), as expected because of a lower volume
of urine production over the shorter night-time period. A
weak correlation was seen between the day- and night-time
samples, with correlation coefficients of 0.375 (p <0.01)
and 0.316 (p <0.01) for women and men, respectively. The
distribution of UIC can be seen in figure 2.
Factors associated with 24-hour UIE
Elimination of variables with the highest significance in
turn did not lower the AIC and BIC values. The fit of the
best model was evaluated graphically, by assessment of
normality of the residuals and by plotting the standardised
residuals against predicted iodine values. Estimates of the
best model (chosen from lowest AIC and BIC) can be seen
in table 2. Variables that were significantly, positively as-
sociated with iodine excretion are male sex, winter season
and 24-hour urinary calcium, selenium and sodium excre-
tions. Age, BMI, eGFR, smoking status and region did not
appear to be associated. Of the foodstuffs, fish appeared to
be the least associated.
EAR Groups
The usual intake distributions shown in figure 3 were cal-
culated using day-time 24-hour normalised values with
night-time 24-hour normalised intakes as a repeated mea-
sure. As can be seen from the graphs, there is a difference
between the distributions for females and males. The
Table 1: Descriptive statistics of the sample population.
Variable Women Men Total
n n n
Mean age (SD), years 48 (17.0) 542 47 (17.8) 482 47 (17.4) 1024
Mean BMI (SD), kgm-2 24.2 (4.7) 542 26.0 (4.2) 482 25.0 (4.5) 1023
Median urine volume (*), ml Day 1100 (759; 1520) 542 1000 (700; 1500) 482 1093 (710; 1500) 1024
Night 487 (300; 700) 542 449 (300; 639) 482 465 (300; 679) 1024
24-hour 1627 (1200; 2200) 542 1524 (1100; 2100) 482 1582 (1119; 2148) 1024
Smoking status, n (%) Current 111 (20) 130 (27) 242 (24)
Ex 155 (29) 161 (34) 322 (31)
Never 276 (51) 179 (37) 459 (49)
Canton, n (%) BE 127 (23) 115 (24) 242 (24)
GE 209 (39) 203 (42) 412 (40)
VD 206 (38) 163 (34) 366 (36)
Season, n (%) Spring 128 (25) 101 (21) 231 (23)
Summer 126 (25) 137 (28) 262 (26)
Autumn 115 (23) 97 (20) 213 (21)
Winter 139 (27) 109 (23) 243 (24)
Mean eGFR (SD), ml/min/1.73m2 94.99 (17.0) 539 98.08 (18.5) 477 96.42 (17.8) 1012
Mean selenium plasma (SD), ng 117.21 (20.4) 486 115.1 (19.4) 426 116.2 (20.0) 908
Median urinary selenium excre-
tion (*), ng
Day 15.25 (11.89; 20.49) 526 20.25 (15.42; 25.50) 465 17.70 (13.04; 22.97) 991
Night 8.72 (6.54; 11.14) 490 10.80 (8.40; 13.86) 444 9.69 (7.30; 12.69) 934
24-hour 23.05 (17.82; 30.12) 541 30.60 (24.07; 37.57) 480 26.83 (19.80; 34.07) 1021
Median urinary calcium excretion
(*), mmol
Day 2.41 (1.19; 4.19) 529 2.58 (1.26; 4.92) 475 2.51 (1.22; 4.41) 1004
Night 0.50 (0.21; 0.99) 531 0.61 (0.27; 1.20 477 0.55 (0.24; 1.08) 1008
24-hour 3.15 (1.76; 5.11) 533 3.34 (1.85; 6.00) 477 3.24 (1.79; 5.38) 1010
Median urinary sodium excretion
(*), mmol
Day 80.43 (57.28; 107.58) 542 104.43 (75.43; 136.00) 482 91.48 (63.93; 122.48) 1024
Night 34.28 (23.53; 49.05) 539 45.00 (29.45; 62.68) 481 38.28 (25.30; 56.29) 1020
24-hour 116.54 (88.52; 151.29) 542 154.96 (120.45; 195.86) 482 134.49 (99.22; 174.68) 1024
Median urinary iodine concentra-
tion (*), µg/l
Day 70.8 (48.1; 105.5) 542 91.2 (63.7; 134.7) 482 79.4 (54.0; 120.2) 1024
Night 84.7 (57.5; 134.2) 542 112.9 (68.8; 164.6$9 482 97.6 (62.2; 150.8) 1024
24-hour 72.8 (53.0; 106.9) 542 96.2 (67.9; 136.2) 482 82.7 (58.1; 121.2) 1024
Median urinary iodine excretion
(*), µg
Day 76.67 (57.20; 102.17) 542 91.14 (69.96; 125.81) 482 82.43 (6313; 113.09) 1024
Night 38.63 (28.59; 54.17) 542 48.69 (34.89; 66.00) 482 43.55 (31.11; 59.53) 1024
24-hour 117.23 (91.98; 152.83) 542 143.93 (112.78; 187.10) 482 128.64 (100.25; 170.95 1024
Median daily iodine intake (*), µg 127.42 (99.98; 166.12) 156.45 (122.59; 203.37) 139.83 (108.97;
185.82)
BE =Bern; eGFR = estimated glomerular filtration rate; GE = Geneva; SD = standard deviation; VD = Vaud
* denotes (25th percentile; 75th percentile)
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prevalence of inadequacy, in other words, the percentage
of population below the EAR of 95µg, is estimated to be
14% for women (13% for women of reproductive age) and
4% for men.
Discussion
The WHO recommends a daily intake of 150 µg of iodine
for adults and the median estimated iodine intake of 140
µg/d (127 and 157 µg/d for women and men, respectively)
is below this level. It is also lower than the intake of 148
µg/d reported in 2014 in a study size of 1420 participants
by Haldimann et al. [46]. König et al. reported intakes of
104 and 98 µg/d (calculated from spot UIC) in a sample of
22 women in Zurich, Switzerland, aged 52–77 years [55].
On the basis of the day and night UIC as large spot sam-
ples, the population of Switzerland would be classed un-
der the WHO criteria as mildly iodine deficient (fig. 2), be-
cause the median concentrations (UICDAY = 79; UICNIGHT
= 98) fall between 50 and 99 µg/l. The wide ranges of urine
volumes, 100–410 0ml and 67–2800ml for day- and night-
time, respectively) suggest that dilution effects should be
considered when interpreting such data [56].
Figure 1: Comparison of measured urinary iodine excretion (UIE) vs day-time:24-hour and night-time:24-hour normalised UIE. Top row: mea-
sured day-time, night-time and 24-hour UIEs for the female (left), male (centre) and entire (right) study population. Bottom row: distributions of
day-time:24-hour normalised, night-time:24-hour normalised excretions together with the measured 24-hour excretion for female, male and en-
tire study population.
Figure 2: Distribution of urinary iodine concentrations (UICs) for day and night samples in the categories of the WHO criteria.
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Inadequacy according to the EAR cut-point method
A more accurate description of iodine intake inadequacy
in a population can be obtained by calculating the per-
centage of samples below the EAR threshold [57]. In this
Swiss sample, the estimated prevalence of inadequate in-
take was 4% for men and 14% for women. This latter value
is above the target range of 2–3% [28, 58] and an espe-
cial cause of concern since “during pregnancy, there are
critical developmental windows in which iodine deficien-
cy may lead to irreversible, adverse brain effects that can-
not be overcome by later iodine sufficiency” [48]. Note
that SKIPOGH samples were collected before the increase
in iodine supplementation of dietary salt from 20–25 ppm,
which took place on 1 January 2014. It will be of interest
to explore the impact of this policy measure in future stud-
ies.
These results are independently validated by those of the
Swiss Salt Survey [46], in which repeat 24-hour urine
samples were collected and which returned an inadequacy
prevalence of 14% for women and 2% for men, after ad-
justment, although it should be noted that the studies were
not carried out on the same participants. We propose that,
instead of a second 24-hour collection, segregation into
day and night collections is sufficient to estimate the preva-
lence of iodine inadequacy by the EAR cut-point method.
Iodine is excreted around 4–5 hours after ingestion [35,
59]; thus, by separating urine collection into day-time and
night-time samples as determined by the participant, we
are in effect separating the iodine ingested during the
morning and early afternoon from that ingested during the
late afternoon and evening. Essentially, this provides two
measurements of dietary intake in a way that is both more
Table 2: Parameter estimates of the best model (LMM, fixed effects) describing the variables that influence the urinary iodine excretion, (a proxy for intake, related by a factor of
0.92).
Effect Estimate Standard error F-Ratio p-Value
Intercept 46.445 28.911 0.109
Sex 6.629 0.010
Female −9.451 3.67 0.010
Male 0 0 .
Age 0.132 0.147 0.8 0.371
BMI 0.923 0.41 4.508 0.034
Season of urine sample 3.03 0.029
Autumn −9.583 4.761 0.039
Spring −3.084 4.71 0.392
Summer −11.788 4.533 0.006
Winter 0 0 .
Daily vegetable portions 2.231 0.064
0 −10.123 16.97 0.551
1 −31.495 13.011 0.016
2 −29.956 12.425 0.016
3 −30.462 12.657 0.016
4 0 0 .
Weekly meat portions 1.035 0.388
A (0–3) 0.425 5.425 0.938
B (4) −0.37 5.419 0.946
C (5) −7.471 5.563 0.180
D (6) 2.421 5.787 0.676
E (7,8) 0 0 .
Weekly fish portions 0.55 0.699
A (0) 7.9 9.967 0.428
B (1) 3.98 7.346 0.588
C (2) 7.989 7.041 0.257
D (3) 8.178 7.475 0.274
E (4+) 0 0 .
Plasma selenium (ng) 0.193 0.092 4.443 0.035
Urinary selenium excretion (µg/d) 0.719 0.127 32.149 <0.001
Urinary calcium excretion (mmol/d) 1.954 0.525 13.855 <0.001
Urinary sodium excretion (mmol/d) 0.347 0.033 111.658 <0.001
Estimated GFR (CKD_EPI) 0.054 0.144 0.143 0.706
Smoking status 1.243 0.289
Current −4.378 4.219 0.300
Ex −5.755 3.901 0.141
Never 0 0 .
Canton 1.57 0.209
Bern 2.788 4.666 0.550
Geneva −4.67 4.023 0.246
Vaud 0 0 .
AIC = Akaike information criterion; BIC = Bayesian information criterion; GFR = glomerular filtration rate
Fit statistics: AIC 8537, BIC 8541
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cost effective and less time consuming for the participants.
We found that correcting the day and night UIEs to 24-hour
excretions leads to a reasonable approximation of the mea-
sured 24-hour excretion (fig. 1). Perrine et al. [37] have
previously shown no consistent variation between excre-
tions calculated from four spot samples taken at different
times. However, in this SKIPOGH study, the timing of the
samples was subject to the participants’ body clocks and
not collected according to a chronological timetable.
Since people tend to vary what they eat both during the day
and from day to day, the iodine content of food and thus in-
take of subsequent days can have a large variation, poten-
tially larger than the variation between individuals of the
sample population. In order to account for this, repeat sam-
ples for some of the population are required. Care should
be taken if data are collected on consecutive days, as food
choice on the first day can influence food choice of the fol-
lowing days [52]. However, this is of less concern for sam-
ples collected within 24 hours, since people rarely eat the
same for breakfast, midday and evening meals. Neverthe-
less, carry-over effects cannot be ruled out.
Factors associated with 24-hour UIE
In contrast to the data (unpublished results) obtained from
the Swiss Salt Survey (SSS) [46], associations between io-
dine intake and eGFR (p = 0.706), smoking status (p =
0.289), or region (p = 0.209) were not significant. The
higher mean iodine for men than for women is expected
since men have a higher salt consumption than women [60]
owing to the tendency to a larger body weight (t = −20.139,
nF = 538, nM = 481, p <0.001) and therefore higher overall
food consumption. Urinary sodium excretion (proxy for
salt intake) showed similar values to those of the SSS study
[46] (mean 3.25 g/d and median of 3.09 g/d, vs meansss
= 3.4 3g/d and mediansss = 3.66 g/d). Likewise, calcium
excretion was similar, with the studies showing a mean =
0.17 vs meansss = 0.16 and median = 0.13 vs mediansss =
0.15 g/d. The significant positive association of 24-hour
urinary calcium excretion with iodine excretion potentially
reflects the contribution of dairy products to iodine intake.
The positive association with the winter season can be ex-
plained by a difference in diet between the winter and sum-
mer months, as well as the documented seasonal variation
of iodine in dairy products [61].
Urinary selenium excretion showed a positive significant
association with iodine intake. A deficiency in selenium
and resulting reduction of deiodinase activity would lead
to a decrease in UIE [62]. An association caused by this
should be visible only in the presence of severe selenium
deficiency, which was not the case in this study. A positive
association between selenium and iodine intake could arise
from selenium levels in foodstuffs containing both, such
as dairy products and bread (grains and seeds). Fish shows
less association with iodine intake than meat and vegeta-
bles. This discrepancy can be explained by the nature of
the food survey questionnaire. Both fruit and vegetables
were recorded on the basis of a daily recall, whereas meat
and fish were recorded as weekly consumption. A recorded
higher weekly fish consumption does not necessarily imply
that fish was consumed on the day of, or prior to, the urine
sample. The relation of UIE with reported meat and veg-
etable consumption should be treated with circumspection,
being more likely attributable to preparation methods (use
of iodised salt, dairy products) rather than any inherent io-
dine content of the food.
Inclusion of the family group as a random effect did not
bring any significant modification to the fit of the model.
On closer inspection of the data, there are family clusters (a
prerequisite of participation), but many do not live togeth-
er. Since all of the participants must be over 18 to partic-
ipate, one would expect children to neither live with their
parents nor follow the same diet throughout the day.
No association between region and iodine intake was
found; however, extrapolating this result to the whole of
Switzerland would not be justified. Switzerland has three
main language regions, with differing cultures, including
nutritive cultures. The SKIPOGH study concentrates on
western Switzerland; the cantons of Geneva and Vaud are
both French language regions and the canton of Bern is on
the border between the French- and German-speaking ar-
eas. The Italian region, and northern and eastern (German
Figure 3: Application of US National Cancer Institute method to estimate the usual iodine intake distribution for all women and all men in the
study population. Cut-off lines are drawn to indicate the estimated average requirement (EAR; 95 µg/d) for both female and male and the top
5% of the intake distribution (268 and 237 µg/d for females and males, respectively); the tolerable upper intake level is 1100 µg/d.
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and Romansch language) regions were not sampled. Com-
paring to the previous SSS study, where region was signif-
icantly associated with iodine intake and the study encom-
passed all language regions, we notice that both Geneva
and Vaud had very similar estimates of effects [46]. In the
SSS study, Bern was not surveyed. It is therefore not sur-
prising that the results of the SKIPOGH study showed no
association with region.
Conclusions
Based on the day and night urine collected from this sam-
ple population between 2009 and 2013, the Swiss adult
population is classified as mildly iodine deficient accord-
ing to the WHO. No association between iodine intake and
eGFR was found. A higher than desirable prevalence of
inadequate iodine intake calculated according to the EAR
cut-point method was shown for women. Drives to lower
salt intake have been countered by an increase of the io-
dine content of iodised salt in recent years, with the intent
to ensure a sufficient supply to the Swiss population. Fur-
ther studies are necessary to monitor the effects of these
two related issues. We propose that a separate collection of
day-time and night-time urine, as determined by the habits
and daily rhythm of the individual participant, is a more
cost effective and efficient way of collecting 24-hour urine
samples to estimate the prevalence of iodine inadequacy
than repeated 24-hour collections.
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